Redhill Biopharma Ltd. (RDHL): Price and Financial Metrics

Redhill Biopharma Ltd. (RDHL)

Today's Latest Price: $4.13 USD

0.08 (1.98%)

Updated Feb 28 12:00am

Add RDHL to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

RDHL Stock Summary

  • For RDHL, its debt to operating expenses ratio is greater than that reported by merely 0.37% of US equities we're observing.
  • RDHL's price/sales ratio is 20.16; that's higher than the P/S ratio of 93.93% of US stocks.
  • Over the past twelve months, RDHL has reported earnings growth of 269.41%, putting it ahead of 95.32% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to RedHill Biopharma Ltd are RMBS, PTCT, XERS, QTNT, and INFI.
  • RDHL's SEC filings can be seen here. And to visit RedHill Biopharma Ltd's official web site, go to
RDHL Daily Price Range
RDHL 52-Week Price Range

RDHL Stock Price Chart More Charts

RDHL Price/Volume Stats

Current price $4.13 52-week high $9.20
Prev. close $4.05 52-week low $3.81
Day low $3.81 Volume 416,800
Day high $4.19 Avg. volume 224,350
50-day MA $5.55 Dividend yield N/A
200-day MA $6.61 Market Cap 90.60M

Redhill Biopharma Ltd. (RDHL) Company Bio

RedHill Biopharma Ltd. focuses on the development and acquisition of late clinical-stage, proprietary, and orally-administered drugs for the treatment of inflammatory and gastrointestinal diseases, including gastrointestinal cancers in Israel. The company was founded in 2009 and is based in Tel Aviv, Israel.

RDHL Latest News Stream

Event/Time News Detail
Loading, please wait...

RDHL Latest Social Stream

Loading social stream, please wait...

View Full RDHL Social Stream

RDHL Price Returns

1-mo -23.80%
3-mo -39.71%
6-mo -45.51%
1-year -46.22%
3-year -56.84%
5-year -71.56%
YTD -31.96%
2019 9.37%
2018 7.98%
2017 -50.86%
2016 -18.79%
2015 -3.38%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.653 seconds.